# \[e-drug\] MaLAM International editions now available

**URL:** <https://talk.edrugplus.org/t/e-drug-malam-international-editions-now-available/8529>\
**Category:** e-drug\
**Created:** [June 26, 2000, 7:47pm UTC](https://talk.edrugplus.org/t/e-drug-malam-international-editions-now-available/8529 "2000-06-26T19:47:55Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![peter.mansfield](https://avatars.discourse-cdn.com/v4/letter/p/c77e96/32.png) [@peter.mansfield](https://talk.edrugplus.org/u/peter.mansfield)\
**Post date:** [June 26, 2000, 7:47pm UTC](https://talk.edrugplus.org/t/e-drug-malam-international-editions-now-available/8529/1 "2000-06-26T19:47:55Z")

</div>

E-drug: MaLAM International editions now available  
-------------------------------------------------------------------------

Dear E-druggers,

3 "new" editions of MaLAM International News are now available on  
the www at:

www.camtech.net.au/malam/Inter.htm

(If you do not have access to www then see below)

The editions are:

March/April 2000 Vol 18 No 3/4  
Healthy Scepticism about Pfizer and Searle�s promotion of celecoxib  
in Australia

January/February 2000 Vol 18 No 1/2  
SKB promotes Augmentin (amoxicillin and potassium clavulinate) in  
Central America with the claim that "generic producers do not reach  
the standard of quality of SmithKline Beecham".

November/December 1999 Vol 17 No 11/12  
Ethics vs Morality (We are proud to publish this beautifully written  
article about dilemmas for community pharmacists written by Raj  
Vaidya, a community pharmacist in Goa, India.)

If you would like to be notified of all future editions then there are 2  
options:

If you have access to E-mail and to the www then please E-mail  
mintwww-request@camtech.net.au with the word "subscribe" in the  
text of your message without the quotation marks and with no other  
words in the message. This is the best option because it enables you  
to see pictures of the advertisements.

If you have access to E-mail but not to www then please E-mail:  
mintemail-request@camtech.net.au with the word "subscribe" in the  
text of your message without the quotation marks and with no other  
words in the message. That will enable you to get future editions text  
only, no pictures. If you want any of the current editions and do not  
have access to the www then please ask me.

Regards,

Peter

Dr Peter Mansfield  
GP and consultant on marketing and quality use of medicines  
Visiting lecturer, Universities of Adelaide, Flinders, South Australia,  
Tasmania  
Cardiovascular adviser, Adelaide Western Division of General Practice  
Quality Use of Medicines Coordinator, Southern (Adelaide) Division of  
General Practice  
Primary author, Healthy Scepticism  
Director, MaLAM (Medical Lobby for Appropriate Marketing)  
MaLAM aims to protect compassionate scientific health care from  
marketing practices that may be detrimental to health.  
peter.mansfield@flinders.edu.au  
www.camtech.net.au/malam  
PO Box 172 Daw Pk SA 5041 Australia  
ph/fax +61 8 8374 2245

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
